0000950170-24-073858.txt : 20240614 0000950170-24-073858.hdr.sgml : 20240614 20240614180759 ACCESSION NUMBER: 0000950170-24-073858 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240614 FILED AS OF DATE: 20240614 DATE AS OF CHANGE: 20240614 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Madaus Martin D CENTRAL INDEX KEY: 0001310268 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-14656 FILM NUMBER: 241046344 MAIL ADDRESS: STREET 1: 290 CONCORD ROAD CITY: BILLERICA STATE: MA ZIP: 01821 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REPLIGEN CORP CENTRAL INDEX KEY: 0000730272 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 042729386 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 41 SEYON STREET STREET 2: BUILDING 1, SUITE 100 CITY: WALTHAM STATE: MA ZIP: 02453 BUSINESS PHONE: 7814499560 MAIL ADDRESS: STREET 1: 41 SEYON STREET STREET 2: BUILDING 1, SUITE 100 CITY: WALTHAM STATE: MA ZIP: 02453 4 1 ownership.xml 4 X0508 4 2024-06-14 0000730272 REPLIGEN CORP RGEN 0001310268 Madaus Martin D C/O REPLIGEN CORPORATION 41 SEYON ST., BLDG 1, STE 100 WALTHAM MA 02453 true false false false false Common Stock 2024-06-14 4 P false 915 124.54 A 3913 D Common Stock 2024-06-14 4 P false 700 125.46 A 4613 D Common Stock 11 I Spouse Trust $124.54 is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $124.25 to $125.21, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate purchase price within the range. $125.46 is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $125.25 to $125.58, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate purchase price within the range. Held by a trust for which the Reporting Person is a trust advisor who shares voting and investment control. /s/ Kimberly Brown (Attorney in Fact) 2024-06-14